Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,344.00
(
-1.59%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.44
(
3.84%
)
Bitcoin
70,464.00
(
0.81%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: gofishmarko post# 27867

Sunday, 04/30/2006 2:09:37 AM

Sunday, April 30, 2006 2:09:37 AM

Post# of 257264
VRTX-The impressive efficacy of VX-950 isn't in question. It's been out there for awhile now about how well the drug clears the HCV viral load. The remaining question mark for VX-950 is safety, specifically the monkey toxicity studies, which have yet to be conducted.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today